Trulicity 1.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FAWL7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,832
Award facts
- Contract value 100% obligated
- $30,832.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,832.27 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on May 14, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to military healthcare programs worldwide.
This delivery order exemplifies the Defense Logistics Agency's medical supply chain operations, specifically supporting the provision of critical pharmaceutical commodities to military and veteran healthcare systems. Trulicity, a diabetes medication, represents the type of specialty and brand-name pharmaceutical products that AmerisourceBergen routinely delivers through its federal contracts. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains a substantial portfolio of competitively awarded contracts with DLA and the Defense Health Agency, demonstrating its capability to meet stringent federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FAWL7?
SPE2DB25FAWL7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 14, 2025.
How much is contract SPE2DB25FAWL7 worth?
The government has obligated $30,832 on SPE2DB25FAWL7.
Is contract SPE2DB25FAWL7 an order under another contract?
Yes. SPE2DB25FAWL7 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAWL7 competed?
The extent of competition for SPE2DB25FAWL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award